<?xml version="1.0" encoding="utf-8" standalone="yes"?><rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom"><channel><title>Pharmaceutical on WebNotes</title><link>https://v2.webnotes.in/tags/pharmaceutical/</link><description>Recent content in Pharmaceutical on WebNotes</description><generator>Hugo</generator><language>en-IN</language><lastBuildDate>Tue, 12 May 2026 00:00:00 +0000</lastBuildDate><atom:link href="https://v2.webnotes.in/tags/pharmaceutical/index.xml" rel="self" type="application/rss+xml"/><item><title>NIFTY Pharma TRI</title><link>https://v2.webnotes.in/nifty-pharma-tri/</link><pubDate>Tue, 12 May 2026 00:00:00 +0000</pubDate><guid>https://v2.webnotes.in/nifty-pharma-tri/</guid><description>&lt;p&gt;The &lt;strong&gt;NIFTY Pharma Total Returns Index&lt;/strong&gt; (&lt;strong&gt;NIFTY Pharma TRI&lt;/strong&gt;) is the dividend-reinvested variant of the NIFTY Pharma index, maintained by &lt;strong&gt;NSE Indices Limited&lt;/strong&gt;. The index covers the 20 largest and most liquid pharmaceutical and healthcare-related companies listed on the &lt;a href="https://v2.webnotes.in/national-stock-exchange/"&gt;National Stock Exchange of India (NSE)&lt;/a&gt;
. India is the world&amp;rsquo;s third-largest pharmaceutical producer by volume and the largest supplier of generic medicines globally; the NIFTY Pharma index reflects this industry&amp;rsquo;s representation in the Indian equity market. The TRI variant is used as the performance benchmark for pharmaceutical and healthcare sector &lt;a href="https://v2.webnotes.in/mutual-fund/"&gt;mutual fund&lt;/a&gt;
 schemes and ETFs.&lt;/p&gt;</description></item></channel></rss>